186 related articles for article (PubMed ID: 11277621)
1. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
Pappagianis D
Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
[TBL] [Abstract][Full Text] [Related]
2. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
3. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
Levine HB; Scalarone GM
Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
[No Abstract] [Full Text] [Related]
4. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
Scalarone GM; Levine HB
Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
[No Abstract] [Full Text] [Related]
5. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
[No Abstract] [Full Text] [Related]
6. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Walch HA; Kalvoda A
Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
[No Abstract] [Full Text] [Related]
7. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
10. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation.
Peng T; Orsborn KI; Orbach MJ; Galgiani JN
J Infect Dis; 1999 Feb; 179(2):518-21. PubMed ID: 9878042
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a potential vaccine for Coccidioides immitis.
Barnato AE; Sanders GD; Owens DK
Emerg Infect Dis; 2001; 7(5):797-806. PubMed ID: 11747691
[TBL] [Abstract][Full Text] [Related]
12. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
13. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
14. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
15. Vaccines against Coccidioides.
Yoon HJ; Clemons KV
Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
[TBL] [Abstract][Full Text] [Related]
16. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
17. Development of vaccines for coccidioidomycosis.
Levine HB; Pappagianis D; Cobb JM
Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
[No Abstract] [Full Text] [Related]
18. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
19. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
20. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]